Oncoliq is a startup that is developing a screening method for early cancer detection based on liquid biopsy using a small blood sample.
Oncoliq has raised $2.8M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Oncoliq's investors include Endurance28, Draper University Ventures, SF500, Draper University, AIR Capital.
Oncoliq is headquartered in Buenos Aires, Argentina.
Oncoliq is a startup that is developing a screening method for early cancer detection based on liquid biopsy using a small blood sample.
Oncoliq is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncoliq — Funding & Investors." VCBacked, April 1, 2025, https://www.vcbacked.co/company/oncoliq. Accessed October 4, 2026.
VCBacked. (2025). Oncoliq — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/oncoliq
{{cite web |title=Oncoliq — Funding & Investors |url=https://www.vcbacked.co/company/oncoliq |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated